UnratedDrug recall · FDA · Published April 23, 2026
JB Chemicals recalls Enalapril tablets due to impurities in organic tests
JB Chemicals recalls 20mg Enalapril Maleate tablets with impurities found in organic tests. This prescription medication was manufactured in India and distributed in the US. Consumers should contact the manufacturer for details.
“JB Chemicals recalls Enalapril tablets due to impurities in organic tests.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31338-jb-chemicals-recalls-enalapril-tablets-due-to-impurities-in-organic. Based on FDA recall #D-0520-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0520-2026%22&limit=1).
The FDA announced on April 23, 2026, that JB Chemicals and Pharmaceuticals Ltd is recalling Enalapril Maleate Tablets, USP, 20 mg, due to failed impurity specifications. The recall affects 675 bottles distributed nationwide.
The recall is due to out-of-specification results in the Organic Impurities Test for Enalapril Maleate Tablets. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show JB Chemicals and Pharmaceuticals Ltd has two other recalls on record since September 12, 2025. On June 24, 2026, the brand recalled Cetirizine Tablets due to cross-contamination with Ranitidine. Other recent recalls of similar products include Sagent Busulfan Injection Recall (May 4, 2026), Ajanta Pharma Fluphenazine Tablets Recall (August 25, 2026), and Macleods Olanzapine Tablets 5mg Recall (August 27, 2026).
How to tell if you have this one
Check for the 20 mg Enalapril Maleate tablets in a 1,000-count bottle with NDC 64980-688-10. The lot number GEH25023 was manufactured in Mumbai, India and expires June 30, 2027.
Brand
JB Chemicals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Medication Details
Look for the NDC 64980-688-10 label on the bottle to confirm if it's the recalled product.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 20 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0520-2026 (April 23, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0520-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.